TrialPath
← Back to searchRecruiting

Phenotyping Genetic Risk for Type 2 Diabetes

NCT04024631 · University of Pennsylvania
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes
About this study
The study team will recruit individuals based on genetic risk score for type 2 diabetes from the biobank populations who have agreed to be recontacted for future research. Each participant will undergo a frequently sampled four-hour oral glucose tolerance test and whole body DXA scan (dual-energy X-ray absorptiometry) in addition to baseline laboratory and history assessment.
Eligibility criteria
Inclusion Criteria: * Age 10-70 years * Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research. * Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher Exclusion Criteria: * prior diagnosis of type 1, type 2, or secondary diabetes * use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication * acute illness that may impact insulin and glucose dynamics * pregnancy * hypothalamic obesity or related genetic disorder of metabolism * recent systemic chemotherapy use * gastrointestinal impairment or surgery that may impact absorption * anemia * major organ system illness or any underlying condition requiring regular medication or treatment that could make implementation of the protocol or interpretation of the study results difficult * inability to comply with study protocol
Study design
Enrollment target: 100 participants
Allocation: na
Masking: none
Age groups: child, adult, older_adult
Timeline
Starts: 2019-06-17
Estimated completion: 2026-06-30
Last updated: 2025-09-10
Interventions
Other: 75g glucose beverage (Glucola, Trutol, or similar brand)Other: DXA, whole body
Primary outcomes
  • Glucose response to an oral glucose load (samples will be collected over four hours and these results will be used to calculate area under the curve)
Sponsor
University of Pennsylvania · other
Contacts & investigators
ContactJessica R Wilson, MD, MS · contact · jessica.wilson3@uphs.upenn.edu · 215 898-3389
ContactEsther Oyerinde · contact · esther.oyerinde@pennmedicine.upenn.edu
InvestigatorJessica R Wilson, MD, MS · principal_investigator, University of Pennsylvania
InvestigatorLorraine Levitt Katz, MD · principal_investigator, Children's Hospital of Philadelphia
All locations (2)
Childrens Hospital of PhiladelphiaNot Yet Recruiting
Philadelphia, Pennsylvania, United States
University of PennsylvaniaRecruiting
Philadelphia, Pennsylvania, United States
Phenotyping Genetic Risk for Type 2 Diabetes · TrialPath